Johnson & Johnson (JNJ) vs Oracle Corporation (ORCL)
See how Johnson & Johnson and Oracle Corporation differ across market data and performance, so you can decide which asset best fits your strategy.
$253.04
NYSE
Johnson & Johnson is the world’s largest and most diversified healthcare company. Its operations are organized into two segments: Innovative Medicine and MedTech, which together account for all revenue following the 2023 separation of its consumer health business, Kenvue. After restructurings completed in 2023 and 2024, the pharmaceutical segment is focused on three core therapeutic areas: immunology, oncology, and neurology. From a geographic perspective, slightly more than half of the company’s total revenue comes from the United States.
Oracle Corporation delivers enterprise applications and infrastructure solutions through flexible IT deployment models, including on-premises, cloud, and hybrid environments. Founded in 1977, Oracle introduced the first commercial SQL-based relational database management system, widely used by many of the world’s largest enterprises for high-volume online transaction processing. In addition to its database products, Oracle offers enterprise resource planning platforms and cloud infrastructure that are becoming increasingly important for large language model training and inference.